AMANDA THACKER: Open Payments
NPI 1114621810 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 19 payments from 9 companies in 2025. Trend: 2023 $58 · 2024 $202 · 2025 $479
Food & beverage: $451Education: $28
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 1 | $92 |
| Insulet Corporation | 4 | $83 |
| Novo Nordisk Inc | 3 | $81 |
| Amgen Inc. | 4 | $68 |
| Medtronic, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $36 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Radius Health, Inc. | 1 | $22 |
Products named: VYVGART, Omnipod, Wegovy, MINIMED 780G, EVENITY, MOUNJARO, Ozempic, UNITHROID.
Industry payments across VA — which companies pay providers there.
